DeepSeek to Raise AI API Prices as Demand for New Models Surges 
AMP Shares Surge 13% After Strong Profit and A$150 Million Buyback 
Alibaba Plans Revenue-Sharing Model for Qwen3.8-Max AI Commercial Users 
Cloudflare Stock Jumps 15% as Earnings Beat Estimates, 2026 Outlook Raised 
Novo Nordisk Raises 2025 Outlook Despite Wegovy Pill Miss and CagriSema Setback 
Nintendo Shares Jump as Switch 2 Sales Boost Earnings 
Sinopec Boosts Russian ESPO Oil Purchases as Middle East Supply Tightens 
OpenAI Restricts Astra AI Over Cyberattack Risks 
Airbnb Stock Jumps After Q2 Earnings Beat, Strong 2026 Outlook 
DBS Raises 2025 Outlook After Record Q2 Profit Driven by Wealth Management 
Shein Scales Back Vietnam Operations as US Trade Rules Shift 
Heineken H1 Operating Profit Meets Forecast as Beer Volumes Beat Expectations 
Daimler Truck Q2 Profit Falls 18%, 2026 Outlook Raised 
SK Hynix, Samsung Lead Asian Chip Stock Selloff After Sandisk, Western Digital Outlook 
Meta Ordered to Pay $567M Over Child Safety Violations in New Mexico 
Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+ 
SoftBank Q1 Profit Beats Forecast as Intel Rally and OpenAI Investments Boost Returns 
SARASOTA, Fla., Feb. 26, 2018 -- Roper Technologies, Inc. (NYSE:ROP) announced that it is presenting at the Raymond James 39th Annual Institutional Investors Conference on Monday, March 5, 2018 at 10:25 AM ET, at the JW Marriott Grande Lakes in Orlando, Florida. A copy of the presentation and a link to the webcast presentation will be available in the “Investors” section of the Company’s website at www.ropertech.com.
About Roper Technologies
Roper Technologies is a constituent of the S&P 500, Fortune 1000, and the Russell 1000 indices. Roper designs and develops software (both software-as-a-service and licensed), and engineered products and solutions for healthcare, transportation, food, energy, water, education and other niche markets worldwide. Additional information about Roper is available on the Company’s website at www.ropertech.com.
Contact Information:
Investor Relations
941-556-2601
[email protected]
